Impact of the duration of posttransplant renal replacement therapy on bacterial infections in liver transplant recipients
β Scribed by Hsin-Yun Sun; Thomas V. Cacciarelli; Marilyn M. Wagener; Nina Singh
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 149 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.22373
No coin nor oath required. For personal study only.
β¦ Synopsis
Whether the duration of renal replacement therapy (RRT) after liver transplantation influences the rate and types of bacterial infections is not known. In this study, 47 of 299 consecutive liver transplant recipients (16%) required posttransplant RRT. The incidence of bacterial infections was higher in the RRT group versus the non-RRT group (8.84 versus 1.38 per 1000 patient days, P < 0.001). In the RRT group, 49% of the patients (23/47) required long-term RRT (30 days), and 51% (24/47) required short-term RRT (<30 days). Long-term RRT (hazard ratio ΒΌ 2.27, 95% confidence interval ΒΌ 1.16-4.47, P ΒΌ 0.017) was a significant predictor of infections. Bacteremia and intra-abdominal infections were the most common sources of infections, and Enterobacteriaceae and enterococci were the predominant pathogens in both groups. The mortality rate for patients requiring RRT was higher than the rate for patients not requiring RRT (P < 0.001), but the mortality rates of the short-term RRT group and the long-term RRT group did not significantly differ (P ΒΌ 0.654). In conclusion, although both short-term RRT and long-term RRT confer a higher risk of bacterial infections, only long-term RRT is a statistically significant predictor of these infections.
π SIMILAR VOLUMES
Patients with clinical acute alcoholic hepatitis (AAH) are not considered suitable candidates for orthotopic liver transplantation (OLT). The histological correlates of AAH are often seen in the explanted liver at the time of transplantation. The importance of these findings remains inconclusive reg
Hepatitis C virus (HCV)-induced cirrhosis is the commonest indication for orthotopic liver transplantation, but HCV recurrence is nearly universal and may worsen patient / graft outcomes. The frequency and severity of HCV recurrence has apparently increased in recent years, raising concern about a p
The prevalence of renal insufficiency before and at 1, 12, and 60 months after liver transplantation (LTx; primary endpoint) and the changes in the glomerular filtration rate (GFR) at same time points according to the immunosuppressive regimen (coprimary endpoint) were investigated. The primary outc
Antiviral therapy after liver transplantation (LT) using interferon (IFN) and ribavirin (RBV) can achieve a sustained virological response (SVR) rate ranging from 20% to 45%. The aims of our study were to assess efficacy and tolerability of therapy, effect on fibrosis progression and the importance